Share class
Morningstar Rating
Bloomberg Ticker
UEGQACE LX
NAV
167.52
23.04.2026
YTD
4.26%
as of 23.04.2026
3M
-%
-
1Y
15.07%
as of 23.04.2026
Share Class name
UBS (Lux) Key Selection SICAV - European Growth and Income (EUR) Q-acc
Overview
The actively managed fund is focused on capturing growth and income opportunities predominantly from Europe.
It invests predominantly in European equities, high yield corporate bonds and convertible bonds.
Each asset class weighting is kept at approximately one third.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
Equities, high yield corporate bonds and convertible bonds offer a compelling combination of growth and income opportunities with favorable risk/return characteristics.
Diversification across each asset class at approximately one third reduces overall risk.
Managed by a dedicated team of experts who can draw upon UBS SA国际传谋's experienced European investment teams.
Risks
This fund value may fluctuate given its equity exposure and is also impacted by changes in interest rates due to its fixed income holdings. The fund focuses intentionally on European assets, which may entail additional risks and volatility. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.
Features
| Product category |
UBS Asset Allocation Funds UBS European Growth and Income Fund |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 (UK) Ltd., London
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
BNP PARIBAS Securities Services
|
| Day of inception |
October 7, 2015
|
| Currency of account |
EUR
|
| Close of financial year |
September 30
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
1.03% p.a.
|
| Management fee |
0.77% p.a.
|
| Total expense ratio (TER) |
1.03% p.a.
|
| Swing pricing |
yes
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
Customized Benchmark
|
| ISIN |
LU1240794898
|
| Bloomberg Ticker |
UEGQACE LX
|
Performance and Prices
Percentage growth
as of April 23, 2026
Cumulative
| EUR(%) | |
| YTD | 4.26 |
| 1M | |
| 3M | |
| 6M | |
| 1Y | 15.07 |
| 2Y | 22.45 |
| 3Y | 32.54 |
| 5Y | 26.51 |
| ø p.a.5Y |
Current data
| Net asset value | 23.04.2026 | EUR 167.52 |
| High - last 12 months | 26.02.2026 | EUR 169.42 |
| Low - last 12 months | 24.04.2025 | EUR 146.02 |
| Assets of the unit class in mn | 23.04.2026 | EUR 0.70 |
| Total product assets in mn | 23.04.2026 | EUR 398.94 |
| Indicative equity dividend yield (gross) | 31.03.2026 | 3.15% |
Structures
By the 10 largest equity positions (in %, as of March 31, 2026)
|
|
|
| ASML HOLDING NV | 0.76 |
| DEUTSCHE TELEKOM AG | 0.66 |
| NOVARTIS AG | 0.65 |
| ASTRAZENECA PLC | 0.63 |
| SHELL PLC | 0.61 |
Fees
Ongoing costs p.a.
1.03%
Flat fee
0.96%
Management fee p.a.
0.77%
Max. issuing commission
4.00%
Max. redemption commission
0.00%
Distribution fee
(see info)
Distributions
No distributions. Continuous reinvestment of income.
Sales Authorisations
Literature
Agreement / Prospectus
|
Document type
|
Document Language
|
|
| Prospectus |
|
|
| Key Information Document |
|
|
| Past performance |
|
|
| Previous performance scenario |
|
|
Annual and semi-annual report (accounting on September 30)
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.